Berrocal-Rubio, Miguel A
Pawer, Yair David Joseph
Dinevska, Marija
De Paoli-Iseppi, Ricardo
Widodo, Samuel S.
Gleeson, Josie
Rajab, Nadia
De Nardo, Will
Hallab, Jeannette
Li, Anran
Mantamadiotis, Theo
Clark, Michael B.
Wells, Christine A.
Funding for this research was provided by:
National Health and Medical Research Council (APP11968410, APP1186371)
Article History
Received: 30 January 2024
Accepted: 19 August 2024
First Online: 29 August 2024
Declarations
:
: Ethics approvals were as follows: The University of Melbourne human ethics committee (approvals 1851831; 1646608; 1851533; 1853511); The University of Melbourne/Florey Institute for Medical Research HREC (approval 12374). The Avenue Hospital Human Research Ethics Committee (Ramsay Health; ethics ID WD00006, HREC reference number 2019/ETH/0050). No human subjects were directly recruited to this study, but use of materials from biobanks (Glioblastoma, adipose tissue, primary blood cells) and use of stem cell lines (iPSC, iPSC-macrophages, iPSC-progenitors, iPSC-neurons) were obtained under review of human ethics committees as detailed above. No data was generated that could lead to reidentification of anonymised materials.
: Not applicable.
: YDJP, RDP and MBC have received support from Oxford Nanopore Technologies (ONT) to present their findings at scientific conferences. However, ONT played no role in study design, execution, analysis or publication. No conflicts are declared for MABR, MD, SSW, NR, WDN, TM or CAW.